Stock Screener App

Gratuito -

Installare

13.49

3.30% -0.46

Cullinan Therapeutics Inc (CGEM)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Cullinan Therapeutics Inc Borsa (CGEM) Ultime notizie

Cullinan Therapeutics flags 2026 as “defining year” at Leerink, tees up key CLN-978/CLN-049 data - MarketBeat

Whale Trades: Can Cullinan Therapeutics Inc outperform under higher oil pricesDividend Hike & Free Safe Capital Growth Stock Tips - baoquankhu1.vn

CGEM Earnings History & Surprises | EPS & Revenue Results | CULLINAN THERAPEUTICS INC (NASDAQ:CGEM) - ChartMill

Analysts Offer Insights on Healthcare Companies: TriSalus Life Sciences (TLSI), Cullinan Management (CGEM) and Pfizer (PFE) - The Globe and Mail

Cullinan Therapeutics (NASDAQ:CGEM) Stock Price Expected to Rise, Wedbush Analyst Says - MarketBeat

Cullinan Therapeutics (CGEM): Wedbush Raises Price Target to $36 - GuruFocus

Cullinan Therapeutics Flags 2026 as Key Year for Clinical Data - Intellectia AI

CGEM: Key T-cell engager programs advance toward pivotal milestones and data readouts in 2026 - TradingView

Cullinan Therapeutics: Q4 Earnings InsightsCullinan Therapeutics (NASDAQ:CGEM) - Benzinga

Cullinan Oncology (CGEM) Projects Strong Cash Position into 2029 - GuruFocus

Cullinan Therapeutics Reports 2025 Financial Results, Updates on CLN-978, Zipalertinib NDA, and 2026 Clinical Milestones - Minichart

Stifel raises Cullinan Oncology stock price target on autoimmune progress By Investing.com - Investing.com South Africa

Cullinan Therapeutics Inc (CGEM) Reports Q4 Earnings - AlphaStreet

Stifel raises Cullinan Oncology stock price target on autoimmune progress - Investing.com

Cullinan Therapeutics (CGEM) Reports Q4 Loss of $0.77 Per Share, Flat Year-Over-Year - AlphaStreet

Cullinan Therapeutics 2025 10-K: Advancing First-in-Class Therapies for Autoimmune Diseases and Cancer, Risks, and Strategic Developments - Minichart

Cullinan Therapeutics 2025 Financial Report: Q4 Loss Beats EstimatesNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform

Cullinan Therapeutics (CGEM) Anticipates Major Developments thro - GuruFocus

Cullinan Therapeutics: Fourth Quarter Earnings Overview - Bitget

Earnings Flash (CGEM) Cullinan Therapeutics Posts Q4 Net Loss $0.77 a Share, vs. FactSet Est of $0.77 Loss - marketscreener.com

Cullinan Therapeutics (NASDAQ:CGEM) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat

Cullinan Therapeutics 10-K — $0 Revenue, Net Loss $219.9M - TradingView

Cullinan Therapeutics: Q4 Earnings Snapshot - KTVB

Cullinan Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2025 ... - bdtonline.com

BRIEF-Cullinan Therapeutics Q4 Operating Expenses USD 55.259 Million - TradingView

Cullinan lines up 2026 lupus and cancer trial results with $439M cash - Stock Titan

Jennifer Michaelson Sells 8,000 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Cullinan Therapeutics Maps 2026 Data Catalysts for Autoimmune CLN-978, AML CLN-049 at TD Cowen Conference - MarketBeat

Blue Owl Capital Holdings LP Has $14.89 Million Position in Cullinan Therapeutics, Inc. $CGEM - MarketBeat

What is Cullinan Therapeutics Incs valuation compared to sector2025 Biggest Moves & Precise Buy Zone Tips - baoquankhu1.vn

Can Cullinan Therapeutics Inc generate free cash flowWeekly Stock Recap & Smart Money Movement Tracker - baoquankhu1.vn

[SCHEDULE 13G] Cullinan Therapeutics, Inc. Passive Investment Disclosure (>5%) - Stock Titan

CGEM: Transformational milestones and pivotal data for autoimmune and AML programs expected by 2026 - TradingView

CGEM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Cullinan Therapeutics (CGEM) Stock Analysis: Exploring A 101% Upside Potential - DirectorsTalk Interviews

Cullinan Therapeutics (NASDAQ:CGEM) Shares Up 7.6%Here's Why - MarketBeat

Cullinan Therapeutics executives to join major healthcare conference fireside chats - Traders Union

Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $25,169.20 in Stock - MarketBeat

Insider Sell: Jennifer Michaelson Sells Shares of Cullinan Thera - GuruFocus

Cullinan Therapeutics (CGEM) CSO sells 1,780 shares in Rule 10b5-1 trade - Stock Titan

CGEM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jennifer Michaelson Sells 1,752 Shares - MarketBeat

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells 3,601 Shares of Stock - MarketBeat

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) Insider Sells $66,301.54 in Stock - MarketBeat

Cullinan Therapeutics (NASDAQ:CGEM) CEO Nadim Ahmed Sells 13,515 Shares - MarketBeat

Cullinan Therapeutics (CGEM) CSO sells 5,353 shares under 10b5-1 plan - Stock Titan

Cullinan Therapeutics (CGEM) CMO sells shares to cover RSU tax bill - Stock Titan

[Form 4] Cullinan Therapeutics, Inc. Insider Trading Activity - Stock Titan

Jennifer Michaelson sells shares under 10b5-1 (CGEM) - Stock Titan

Cullinan Therapeutics (NASDAQ:CGEM) Hits New 12-Month HighWhat's Next? - MarketBeat

Cullinan Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewswire

Cullinan Therapeutics: Thesis Strengthening For T-Cell Engager Specialist (NASDAQ:CGEM) - Seeking Alpha

Jennifer Michaelson Sells 11,742 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock - MarketBeat

Cullinan Therapeutics (NASDAQ:CGEM) Insider Jeffrey Alan Jones Sells 4,982 Shares - MarketBeat

Insider Selling: Cullinan Therapeutics (NASDAQ:CGEM) CFO Sells 4,398 Shares of Stock - MarketBeat

Cullinan Therapeutics (CGEM) CMO sells 4,982 shares for RSU tax obligations - Stock Titan

Cullinan Therapeutics (CGEM) CSO exercises options and sells 11,742 shares - Stock Titan

Cullinan Therapeutics (CGEM) CLO sells 3,742 shares to cover tax - Stock Titan

Cullinan Therapeutics (CGEM) CEO sells shares to cover RSU tax bill - Stock Titan

Cullinan Therapeutics (CGEM) CFO sells shares to cover RSU tax bill - Stock Titan

CGEM (NASDAQ: CGEM) Form 144 shows 1,752-share proposed resale; insider sales listed - Stock Titan

Cullinan Therapeutics Inc expected to post a loss of 81 cents a shareEarnings Preview - TradingView

Is Cullinan Therapeutics Inc. benefiting from innovation trendsCEO Change & Detailed Earnings Play Strategies - mfd.ru

Cullinan Therapeutics (NASDAQ:CGEM) Cut to Hold at Zacks Research - Defense World

Cullinan Therapeutics (NASDAQ:CGEM) Stock Rating Lowered by Zacks Research - MarketBeat

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech With 120% Upside Potential - DirectorsTalk Interviews

Will Cullinan Therapeutics Inc. stock recover faster than peersJuly 2025 PreEarnings & Smart Money Movement Alerts - mfd.ru

What is the long term forecast for Cullinan Therapeutics Inc. stockJuly 2025 Sentiment & Detailed Earnings Play Alerts - mfd.ru

RPRX

$45.65

0.48%

ROIV

$28.06

1.72%

MRNA

$52.56

1.55%

BNTX

$91.19

1.21%

INSM

$139.50

0.01%

ONC

$284.05

0.44%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters